JHIU
RARE icon

Janus Henderson Investors US’s Ultragenyx Pharmaceutical RARE Stock Holding History

Janus Henderson Investors US’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-32,330
Closed -$1.45M – 1120
2014
Q2 		$1.45M Sell
32,330
-28,135
-47% -$1.16M ﹤0.01% 915
2014
Q1 		$2.96M Buy
+60,465
New +$3.11M ﹤0.01% 830

Other funds holding RARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Janus Henderson Investors US's RARE Position: Q3 2014 in Review

Janus Henderson Investors US sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2014, closing a stake of 32,330 shares — an estimated $1.45M sold.

Janus Henderson Investors US first reported a position in RARE in Q1 2014 and held it in 2 quarters. The position peaked at $2.96M in Q1 2014. 100 funds tracked by Wall St. Rank hold RARE as of Q3 2014.

  • Janus Henderson Investors US reported no remaining Ultragenyx Pharmaceutical position as of Q3 2014 after selling out during the quarter.
  • Janus Henderson Investors US sold 32,330 Ultragenyx Pharmaceutical shares in Q3 2014, an estimated $1.45M.
  • Janus Henderson Investors US first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 2 quarters.
  • Janus Henderson Investors US's Ultragenyx Pharmaceutical position peaked at $2.96M in Q1 2014.
  • 100 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2014.

Based on Janus Henderson Investors US's 13F filing for Q3 2014, filed 14 Nov 2014.